Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net loss	$ (4,226,617)	$ (1,983,711)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	8,246	17,506
Depreciation and amortization	6,527	4,641
Change in fair value of derivative instrument-warrants	9,680	(195,917)
Change in fair value of contingent consideration	30,000	100,000
Change in fair value of debt		59,641
Non-cash interest expense		23,906
Amortization of debt discount recorded as interest expense		69,516
Changes in operating assets and liabilities:
Accounts payable and accrued expense	277,715	(46,188)
Prepaid expenses and other assets	(783,513)	(107,821)
Net cash used in operating activities	(4,677,962)	(2,058,427)
Cash flows from investing activities:
Purchase of property and equipment		(37,849)
Proceeds from disposal of property and equipment	2,194
Net cash provided by (used in) investing activities	2,194	(37,849)
Cash flows from financing activities:
Proceeds from the issuance of common stock, net of issuance costs	6,788,465
Proceeds from the exercise of warrants	12,000
Proceeds from issuance of short term debt and common stock		1,250,000
Repayment of debt financing		(303,547)
Net cash provided by financing activities	6,800,465	946,453
Net increase (decrease) in cash	2,124,697	(1,149,823)
Cash at beginning of period	13,922,972	2,832,429
Cash at end of period	$ 16,047,669	1,682,606
Supplementary disclosure of cash flow information:
Cash paid for interest		8,953
Supplementary disclosure of non-cash financing activities:
Conversion of Series C convertible preferred stock (part of Series C deemed dividend)		46,000
Accretion of Series C preferred stock discount upon conversion		24,321
Issuance of common stock for debt redemption		126,094
Adoption of lease accounting		$ 733,374